XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.2

Segment Information (Tables)

6 Months Ended

Jul. 01, 2022

Segment Reporting [Abstract]

Schedule of Reconciliation of Revenue from Segments to Consolidated

The following table presents sales by product line (in thousands):

			Three Months Ended												Six Months Ended
			July 1, 2022						July 2, 2021						July 1, 2022						July 2, 2021
Segment sales by product line:
Medical
Cardio & Vascular			$	180,604					$	144,683					$	339,641					$	285,889
Cardiac Rhythm Management & Neuromodulation			135,945						133,660						259,269						255,363
Advanced Surgical, Orthopedics & Portable Medical			23,285						23,283						42,951						43,339
Total Medical			339,834						301,626						641,861						584,591
Non-Medical			10,247						10,397						19,132						17,899
Total sales			$	350,081					$	312,023					$	660,993					$	602,490

Schedule of Reconciliation of Operating Profit (Loss) from Segments to Consolidated

The following table presents income for the Company’s reportable segments (in thousands):

			Three Months Ended												Six Months Ended
			July 1, 2022						July 2, 2021						July 1, 2022						July 2, 2021
Segment income:
Medical			$	54,580					$	56,439					$	98,728					$	111,964
Non-Medical			1,625						3,356						2,290						3,358
Total segment income			56,205						59,795						101,018						115,322
Unallocated operating expenses			(23,498)						(20,445)						(45,814)						(41,364)
Operating income			32,707						39,350						55,204						73,958
Unallocated expenses, net			(8,284)						(8,572)						(16,833)						(18,202)
Income before taxes			$	24,423					$	30,778					$	38,371					$	55,756

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration